Progress toward a Universal H5N1 Vaccine: A Recombinant Modified Vaccinia Virus Ankara-Expressing Trivalent Hemagglutinin Vaccine

Mookkan Prabakaran; Sonja Leyrer; Fang He; Sebastian Auer; Subaschandrabose R. Kumar; Kathrin Kindsmueller; Nutan Mytle; Joerg Schneider; Stephen Lockhart; Jimmy Kwang

doi:10.1371/journal.pone.0107316

Loading metrics

Open Access

Peer-reviewed

Research Article

Progress toward a Universal H5N1 Vaccine: A Recombinant Modified Vaccinia Virus Ankara-Expressing Trivalent Hemagglutinin Vaccine

Mookkan Prabakaran ,

Contributed equally to this work with: Mookkan Prabakaran, Sonja Leyrer

Affiliation Animal Health Biotechnology, Temasek Life Sciences Laboratory, National University of Singapore, Singapore, Singapore
⨯
Sonja Leyrer ,

Contributed equally to this work with: Mookkan Prabakaran, Sonja Leyrer

* E-mail: kwang@tll.org.sg (JK); leyrers@ebsi.com (SL)

Affiliation Emergent BioSolutions Inc., Rockville, Maryland, United States of America
⨯
Fang He,

Affiliation Animal Health Biotechnology, Temasek Life Sciences Laboratory, National University of Singapore, Singapore, Singapore
⨯
Sebastian Auer,

Affiliation Emergent BioSolutions Inc., Rockville, Maryland, United States of America
⨯
Subaschandrabose R. Kumar,

Affiliation Animal Health Biotechnology, Temasek Life Sciences Laboratory, National University of Singapore, Singapore, Singapore
⨯
Kathrin Kindsmueller,

Affiliation Emergent BioSolutions Inc., Rockville, Maryland, United States of America
⨯
Nutan Mytle,

Affiliation Emergent BioSolutions Inc., Rockville, Maryland, United States of America
⨯
Joerg Schneider,

Current address: GlycoVaxyn AG, Schlieren, Switzerland

Affiliation Emergent BioSolutions Inc., Rockville, Maryland, United States of America
⨯
Stephen Lockhart,

Affiliation Emergent BioSolutions Inc., Rockville, Maryland, United States of America
⨯
Jimmy Kwang

* E-mail: kwang@tll.org.sg (JK); leyrers@ebsi.com (SL)

Affiliation Animal Health Biotechnology, Temasek Life Sciences Laboratory, National University of Singapore, Singapore, Singapore
⨯

Progress toward a Universal H5N1 Vaccine: A Recombinant Modified Vaccinia Virus Ankara-Expressing Trivalent Hemagglutinin Vaccine

Mookkan Prabakaran,
Sonja Leyrer,
Fang He,
Sebastian Auer,
Subaschandrabose R. Kumar,
Kathrin Kindsmueller,
Nutan Mytle,
Joerg Schneider,
Stephen Lockhart,
Jimmy Kwang

Published: September 17, 2014
https://doi.org/10.1371/journal.pone.0107316

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

H5N1
Is the Subject Area "H5N1" applicable to this article?

Thanks for your feedback.
Viral vaccines
Is the Subject Area "Viral vaccines" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Influenza A virus
Is the Subject Area "Influenza A virus" applicable to this article?

Thanks for your feedback.
Guinea pigs
Is the Subject Area "Guinea pigs" applicable to this article?

Thanks for your feedback.
Vaccinia virus
Is the Subject Area "Vaccinia virus" applicable to this article?

Thanks for your feedback.